| ●Editorial | Nomoto M | 184-5 | Full text | |
| ●The 14th Setouchi International Conference on Clinical Trials | 187-248 | Abstract | ||
| Organizers：Nomoto M，Kageyama S，Araki H，Moritoyo T， Yanagawa H，Ohashi K，Nakamura T Organized by：Clinical Research Trial Center, Ehime University Hospital | ||||
| Opening remarks | Nomoto M | 189 | ||
| Screening of drugs that activate membrane trafficking using serotonin transporter | Sakai N | 190-5 | ||
| Pelvic blood flow and overactive bladder | Saito M | 196-201 | ||
| The reference values of laboratory tests for clinical trials | Nomoto M | 202-6 | ||
| Clinical research based on clinical pharmacology How can we bridge the gap between biomarkers and outcomes? | Ueda S | 207-12 | ||
| Clinical research support system in Yamaguchi University Hospital | Umemoto S | 213-8 | ||
| Attempt to establish infrastructure for clinical research at Tokushima University Hospital | Yanagawa H | 219-24 | ||
| Supportive ARO in Kochi University | Iiyama T，Asano K | 225-31 | ||
| Role of clinical pharmacology to encourage clinical research in Japan | Watanabe H | 232-7 | ||
| Contribution of clinical pharmacology to daily medical practice | Harada K | 238-42 | ||
| Problem of polypharmacy in community health care | Kawamoto R | 243-7 | ||
| Closing remarks | Nomoto M | 248 | ||
| ●The past, present and future of bioethics and research ethics (Part I) | ||||
| Bioethics and an Idea of Life: Civic Action to Enhance Human Dignity －Interview with Professor Rihito Kimura－ | Kimura R （Interview by Kurihara C） | 249-63 | Full text | |
| The significance of ELM: A facility of advocacy for patients and the general public | Konishi T | 265-71 | Abstract | |
| An attempt to understand clinical research support | Yoshida M | 273-5 | Abstract | |
| Research ethics in emergent situation: Ethical review and monitoring | Iijima Y | 277-82 | Abstract | |
| Current status, issues and future prospects of uterus transplantation | Kisu I | 283-90 | Abstract | |
| Neurosurgical treatment for mental disorders－Critical issues for considering clinical trial in Japan－ | Nudeshima J | 291-7 | Abstract | |
| East German scandal on clinical trial: At the height of the Cold War | Saio T，Kurihara C | 299-306 | Abstract | |
| Proposal for the implementation of Medical Advisory Board Meeting | Inoue Y，Mihara H， Tomohira Y，et al． | 307-16 | Abstract | |
| Revision of Clinical Trial Compensation Guideline in Japan －History of revisions and our thoughts on recent questions－ | Nabeoka Y，Sawada S， Saito Y，et al． | 317-28 | Abstract | |
| Institutional compensation system for protection of human subjects: Appropriate
compensation and treatment for subjects who are harmed as a result of participating in clinical research | Kasai H，Kurihara C， Suzuki C，et al． | 329-68 | Abstract | |
| Right of human research subject and compensatory justice: Ethical considerations | Kurihara N，Kurihara C | 369-80 | Abstract | |
| ●Article | ||||
| Contested illness to solve the social issues in modern medicine: Beyond mind-body dualism | Saio T | 381-6 | Full text | |
| ●Instructions for authors［Japanese］＆［English］ | 387-95 | Full text | ||
| ●Editor’s note | Kurihara M | 397 | Full text | |